These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [The evolution of peculiar disorders of rhythm and conduction in acute myocardial infarct]. Martinelli M; Posteli T; Civiero G; Ferramosca B Boll Soc Ital Cardiol; 1970; 15(6):544-50. PubMed ID: 5517651 [No Abstract] [Full Text] [Related]
43. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate. Hope RR; Williams DO; el-Sherif N; Lazzara R; Scherlag BJ Circulation; 1974 Sep; 50(3):507-14. PubMed ID: 4416250 [No Abstract] [Full Text] [Related]
45. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Hellestrand KJ Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822 [No Abstract] [Full Text] [Related]
46. [Drug therapy of arrhythmias]. Bender F; Schmidt E; Gradaus D Schweiz Med Wochenschr; 1969 Oct; 99(43):1539-42. PubMed ID: 5362117 [No Abstract] [Full Text] [Related]
47. [Cardiac arrhythmias. I. Pathogenesis and clinical significance]. Schollmeyer P Med Klin; 1971 Apr; 66(16):613-9. PubMed ID: 4101688 [No Abstract] [Full Text] [Related]
48. [Clinical value of Neo-Gilurytmal in the treatment of arrhythmias]. Kedrowa S; Kutarski A Pol Tyg Lek; 1976 Feb; 31(6):241-3. PubMed ID: 1257134 [No Abstract] [Full Text] [Related]
51. Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction. Terry G; Vellani CW; Higgins MR; Doig A Br Heart J; 1970 Jan; 32(1):21-5. PubMed ID: 5417842 [No Abstract] [Full Text] [Related]
52. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Bergey JL; Nocella K; McCallum JD Eur J Pharmacol; 1982 Jul; 81(2):205-16. PubMed ID: 7117374 [TBL] [Abstract][Full Text] [Related]
53. Maine Heart Association notes. Dana JB J Maine Med Assoc; 1970 Mar; 61(3):63-4. PubMed ID: 4392007 [No Abstract] [Full Text] [Related]
54. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias. Nestico PF; DePace NL; Morganroth J Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595 [TBL] [Abstract][Full Text] [Related]
55. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. Schmid JR; Hanna C J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702 [No Abstract] [Full Text] [Related]
56. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents. Shalsha KG Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617 [No Abstract] [Full Text] [Related]
57. [Use of lidocaine in the treatment of ventricular arrhythmias]. Antonini FM; Fumagalli C; Bertini G; Ricci F Cardiol Prat; 1970 Jun; 21(3):141-54. PubMed ID: 5511551 [No Abstract] [Full Text] [Related]
58. The role of antiarrhythmic drugs in prevention of sudden cardiac death. Podrid PJ Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903 [No Abstract] [Full Text] [Related]
59. [Possibilities of drug therapy of arrhythmias in myocardial infarct]. Kozená J; Kolár J Cas Lek Cesk; 1971 May; 110(19):437-41. PubMed ID: 5574742 [No Abstract] [Full Text] [Related]
60. Reappraisal of digitalis. X. Treatment of digitalis toxicity. Lyon AF; DeGraff AC Am Heart J; 1967 Jun; 73(6):835-7. PubMed ID: 4961018 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]